Lynx BiosciencesHealthfalse

Oncology Therapeutics · Cell & Gene Therapy

Overview

LynxBio is a clinical-stage biotechnology company combining physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep learning analytics with the goal of rapidly advancing drug candidates in oncology and bringing personalized cancer treatments to patients.

Funding and backers

Backers
1
Great Oaks Venture Capital
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Great Oaks Venture Capital fund
Investors in similar startupsfunds that back the companies most like this one
RA Capital Management
backs Solstice Oncology
Foresite Capital
backs Lyell
Oxford Technology
backs Bioarchitech
Illumina Ventures
backs Actym Therapeutics
Deep Science Ventures
backs Stratosvir
venBio Partners
backs Lyell
Similar startupsby what they do, their industry and backers
Lyell51-200 employees · 5 roles
Learn about Lyell and how we are building an industry-leading clinical-stage pipeline of CAR-T cell product candidates for cancer.
StratosvirVenture round · 8 mo ago · Founded 2020
Stratosvir. Revolutionizing cancer treatment through viral immunotherapy.
Solstice OncologySeries A $225M · 1 mo ago · Founded 2026 · 51-200 employees
Solstice Oncology is a clinical stage immuno-oncology company developing a therapeutic that meets cancer at its most vulnerable moment…
Eisbach Bio GmbHVenture round · 22 mo ago · Founded 2019 · 11-50 employees
Eisbach Bio is a clinical-stage biotechnology company developing next-generation cancer therapies with its proprietary ALLOS platform.
BioarchitechVenture round · 11 mo ago · 11-50 employees
Bioarchitech develops multifunctional immunotherapies targeting cancer and virus-related diseases, including innovative viral and RNA-based…
Actym TherapeuticsSeries A · 1 mo ago · 51-200 employees
Actym Therapeutics is deploying its biologically brilliant bacteria drug delivery platform to treat cancer with powerful immunotherapies…

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
Great Oaks Venture CapitalVia a fund
195 portfolio companies: SmithRx, SocialSign.in, Soil ConnectMarketplacefalse and 192 more
Report a mistake

News

Blog 5 years ago
Lynx Biosciences Appoints Sylvaine Cases, Ph.D., as Chief Business Officer
SAN DIEGO, November 17, 2021 - Lynx Biosciences, Inc. (LynxBio), a biotechnology company generating unparalleled biological insights...
Read more
Report